PubMed Health⌕ Search

Biomedical subjects

Kjeld Møller Pedersen

Publications and source records attributed to Kjeld Møller Pedersen.

10 recordsLinked to original sources
PubMed2006

[Obesity and health economics. Review and status].

Cost-of-illness analyses are concerned with the societal economic impact of obesity such as treatment-costs and lost production related to morbidity and mortality. As regards allocation of resources a growing number of cost-effectiveness analyses of different interventions have appeared. In addition several economic analyses look at how obesity affects wage level and how the use of price-subsidies affects the consumption of products and services. Most recently health economic analyses of possible explanations of the rise in the prevalence of obesity have emerged.

Anti-Obesity Agents↗
PubMed2005

The Danish health care system: evolution--not revolution--in a decentralized system.

The Danish health care system has undergone gradual changes, but not radical reforms, from 1970 until 2004. Theoretically, the development can be viewed from the perspective of fiscal federalism, decentralization, and incentives embodied in reimbursement systems. Furthermore, path dependence and incrementalism have characterized the system. The Danish health care system is decentralized politically, financially, and operationally. The counties are responsible for health care, and finance it out of county income and property taxes along with block grants from the state. Hospitals are publicly owned while general practitioners are private entrepreneurs working on contract with the counties. Hospital services and GP and specialist services are free, while there are co-payments for drugs, adult dental care, physiotherapy and the like. Co-payments make up close to 19% of total health expenditures. The system has been characterized by expenditure control, reasonable positive development in productivity, and a high degree of patient and citizen satisfaction despite waiting lists. Free choice of hospital was introduced more than 10 years ago. It has recently been expanded so that after waiting 2 months for treatments like elective surgery at public hospitals, citizens can choose either private hospitals or go abroad with full payment from public funds. The thinking behind decentralization gradually has been eroded for a number of reasons. This has led to a reform that will be effective as of January 2007. The number of counties will be reduced, but the new regions retain responsibility for health care. A national earmarked health tax will be introduced so that the regions will receive revenues from state block grants and municipal co-payment, for instance an amount per hospitalization.

Denmark↗
PubMed2004

[Lost hope...].

Explore the source record for details and available documents.

Humans↗
PubMed2003

[Pharmacoeconomics--survey and status].

Pharmacoeconomics is a subdiscipline of health economics. There are two main areas of application: economic evaluation (cost-effectiveness, cost-utility and cost-benefit analysis) and regulation of the drug market, e.g. price control, reimbursement mechanisms linked to prices (reference prices), parallel trade, research and development (R&D), and patents. It is shown how price regulation has led to price stability in the Danish drug market with a price level on or [table: see text] slightly below the European level. The basic principles of cost-effectiveness analysis are outlined followed by a critical discussion of the use of guidelines in connection with application for reimbursement. It is noted that many methodological problems still have not been settled definitively leading to many low quality economic evaluations.

Cost-Benefit Analysis↗